Role of Substance P in Post-Traumatic Stress Disorder
NCT00102102 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2008-03-04
Summary
This study will examine the role of substance P, a chemical messenger in the brain, in post-traumatic stress disorder (PTSD), a chronic anxiety disorder. PTSD can develop after exposure to a terrifying event or ordeal, such as a violent personal assault, natural or human-caused disaster, accident, or military combat. Substance P is a peptide that may be important in the response to certain psychiatric and neurological diseases and conditions, including anxiety.
Healthy normal volunteers and people with PTSD who are between 18 and 65 years of age may be eligible for this study. Candidates are screened with a physical examination, blood and urine tests, pregnancy test for women who can become pregnant, and a neuropsychological evaluation.
Participants undergo positron emission tomography (PET) and magnetic resonance imaging (MRI) scanning. An optional lumbar puncture (spinal tap) is also requested.
PET Scanning
PET uses small amounts of a radioactive chemical called a tracer that "labels" active areas of the brain. The tracer used in this study is \[18F\]SPA-RQ. For the procedure, the subject lies still on the scanner bed. A special mask is fitted to the head to help keep the subject's head still during the scan so the images will be clear. A 20-minute "transmission" scan is done before the radioactive tracer is injected to provide measures of the brain that will help in the precise calculation of information from subsequent scans. After the tracer is injected through a needle in the arm, pictures are taken continuously for about 2 hours. Then, 20- to 40-minute images are taken every hour until about 5 hours after the injection.
MRI Scanning
An MRI scan is scheduled at some time within 1 year of the PET scan. MRI uses a magnetic field and radio waves to obtain images of body tissues and organs. The subject lies still on a table inside the tunnel-like MRI scanner. Earplugs are worn to muffle loud noises that occur during the scanning. The maximum duration of the scan is 60 minutes.
Lumbar Puncture
Lumbar puncture is used to examine the cerebrospinal fluid (CSF) that surrounds both the brain and the spinal cord. For this procedure, a local anesthetic is given to numb the skin in the lower back area. A small needle is then inserted into the space between the bones in the lower back where the CSF circulates below the spinal cord. A small amount of fluid is collected through the needle.
Blood Draw
A blood sample is collected to generate cell lines that can be used to extract DNA (genetic material) for gene studies and that can be frozen for future use.
Conditions
- Post-Traumatic Stress Disorder
Interventions
- DRUG
-
[18F]SPA-RQ
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-01-31
- Completion
- 2006-01-31
Countries
- United States
Study Locations
More Related Trials
-
Effects of Stellate Ganglion Block in Post-traumatic Stress Disorder
NCT05391971 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Neural Circuits in Women With Abuse and Posttraumatic Stress Disorder
NCT01681849 ·Status: COMPLETED ·Phase: PHASE4
-
Targeting Cognition in PTSD: Pregnenolone Augmentation of SSRIs
NCT00560781 ·Status: COMPLETED ·Phase: NA
-
Mild Traumatic Brain Injury and Post-Traumatic Stress Disorder
NCT01547819 ·Status: WITHDRAWN
-
Effect of Propranolol on Preventing Posttraumatic Stress Disorder
NCT00158262 ·Status: COMPLETED ·Phase: PHASE4
-
Developing Memory Reconsolidation Blockers as Novel Posttraumatic Stress Disorder (PTSD) Treatments
NCT01490697 ·Status: COMPLETED ·Phase: PHASE4
-
Relationship Between the Biological and Psychological Correlates of PTSD
NCT00183300 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging the Neuroimmune System in PTSD
NCT04236986 ·Status: COMPLETED ·Phase: PHASE1
-
Neurosteroids for PTSD in Veterans
NCT03799562 ·Status: COMPLETED ·Phase: PHASE2
-
Short Course Glucocorticoid Treatment for PTSD
NCT00204737 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans
NCT05876481 ·Status: UNKNOWN ·Phase: PHASE2
-
Cerebral GABA and Fear Conditioning in PTSD
NCT01800383 ·Status: COMPLETED
-
A Randomized, Placebo-Controlled Trial of Stellate Ganglion Block in the Treatment of Post Traumatic Stress Disorder
NCT01629537 ·Status: COMPLETED ·Phase: PHASE2
-
Neural Correlates of Early Intervention for Posttraumatic Stress Disorder (PTSD)
NCT00665678 ·Status: TERMINATED ·Phase: PHASE4
-
Post-Traumatic Stress Disorder (PTSD) Symptom Study
NCT00018798 ·Status: COMPLETED
-
Norepinephrine Transporter Availability in PTSD
NCT01799837 ·Status: COMPLETED ·Phase: PHASE1
-
Prolonged Exposure and Oxytocin
NCT03238924 ·Status: COMPLETED ·Phase: PHASE2
-
Intensive Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)
NCT01120067 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Use of Methylone in the Treatment of PTSD
NCT05741710 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Predicting Responses to PTSD Treatment With Iris and Cardiovascular Tests
NCT03539614 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Carvedilol Versus Placebo for Treatment in Post Traumatic Stress Disorder (PTSD)
NCT01221792 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Smoking Among Individuals With PTSD
NCT00937235 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Riluzole to Treat Post-traumatic Stress Disorder (PTSD)
NCT02155829 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PTSD Symptom Reduction by Propranolol Given After Trauma Memory Activation
NCT00645450 ·Status: TERMINATED ·Phase: PHASE4
-
Brain Imaging of Psychotherapy for Posttraumatic Stress Disorder (PTSD)
NCT01507948 ·Status: COMPLETED ·Phase: NA